Pharma IT ManCo ApS
CVR 43329782 · Private limited company (ApS) · Active · Low risk
Pharma IT ManCo ApS is a Private limited company (ApS), founded on , based in Hvidovre. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 4 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 27.7m and a net result of DKK -9.3m. CEO: Jakob Juul Rasmussen, Søren Winkel, Peter-Emil Iversen.
Bankruptcy risk for Pharma IT ManCo ApS
0.0 × the average (1.41%) · higher risk than 33% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43329782
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (4 years)
- Address
- c/o JaJR Holding ApS, Søbyvej 11
2650 Hvidovre - Municipality
- Hvidovre
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 50k
- Auditor
- REDMARK, GODKENDT REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 4 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 80.9% |
| Current ratio | 0% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 15 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Revenue | DKK 0 | DKK 0 |
| Gross profit | DKK -39k | DKK -35k |
| Net profit | DKK -9.3m | DKK 27.5m |
| Equity | DKK 27.7m | DKK 85.8m |
| Total assets | DKK 34.3m | DKK 102.5m |
| Cash | DKK 3,958 | – |
| Short-term debt | DKK 6.6m | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Redmark, Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 168 | ||
| 15 Jun 2022 – 31 Dec 2022 | 185 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Jakob Juul Rasmussen | Current | |
| CEO | Søren Winkel | Current | |
| CEO | Peter-Emil Iversen | Current | |
| Owner (15%) | PEI Holding ApS | Current | |
| Owner (33%) | SqWi Holding ApS | Current | |
| Owner (25%) | JaJR Holding ApS | Current | |
| Owner (15%) | Pharma IT ManCo ApS | Current | |
| Owner (33%) | JaJR Holding ApS | ||
| Auditor | REDMARK, GODKENDT REVISIONSPARTNERSELSKAB | Current | |
| Founder | PEI Holding ApS | Current | |
| Founder | JaJR Holding ApS | Current | |
| Founder | SqWi Holding ApS | Current |
The CEOs' other companies
Jakob Juul Rasmussen – 19 other companies
- ArnBo 64b ApS Active
- Arnbo 62 ApS Active
- DJKL Holding ApS Active
- FJKL Holding ApS Active
- HP Properties ApS Active
- Hammerholmen 4X ApS Active
- JAJR Ejendomme 2 ApS Active
- JAJR Ejendomme ApS Active
- JaJR Holding 2 ApS Active
- JaJR Holding ApS Active
- Neo Biopharm ApS Active
- Ombytningsselskabet Pharma IT ApS Fusioneret
- Pecunia IT Consulting ApS Active
- Pharma IT ApS Active
- Pharma Lab CRO ApS Active
- ProductLife ApS Active
- ProductLife Group ApS Active
- Radyx Pharma Tech ApS Active
- SJKL Holding ApS Active
Søren Winkel – 7 other companies
- Pecunia IT Consulting ApS Active
- Pharma IT ApS Active
- ProductLife ApS Active
- RABELL ApS Active
- SqWi Holding ApS Active
- WISCH ApS Active
- Winkelorama ApS Active
Peter-Emil Iversen – 3 other companies
- Iver Hus ApS Active
- PEI Holding ApS Active
- Pharma IT ApS Active
Address history (0 moves)
| c/o JaJR Holding ApS, Søbyvej 11, 2650 Hvidovre |
Other companies at the same address
- Kant IVS Bankrupt
- ArnBo 64b ApS Active
- Arnbo 62 ApS Active
- DJKL Holding ApS Active
- FJKL Holding ApS Active
- HP Properties ApS Active
- Hammerholmen 4X ApS Active
- JAJR Ejendomme 2 ApS Active
- JAJR Ejendomme ApS Active
- JaJR Holding 2 ApS Active
- JaJR Holding ApS Active
- Ombytningsselskabet Pharma IT ApS Fusioneret
- Pecunia IT Consulting ApS Active
- Pharma Lab CRO ApS Active
- SJKL Holding ApS Active
Similar companies in Hvidovre
- JØRGEN HOLM HOLDING A/S Hvidovre
- TM1992 Holding ApS Hvidovre
- 2Win ApS Hvidovre
- Flatmo Holding ApS Hvidovre
- LIMS invest ApS Hvidovre
- eXo Skins Holding ApS Hvidovre
- Wonderworld Holding ApS Hvidovre
- PH Capital ApS Hvidovre
- OK Capital ApS Hvidovre
- Farlig Lasse ApS Hvidovre
- CFN2026 Holding ApS Hvidovre
- LPO Generations Holding ApS Hvidovre
Questions and answers about Pharma IT ManCo ApS
Has Pharma IT ManCo ApS gone bankrupt?
No, Pharma IT ManCo ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Pharma IT ManCo ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of Pharma IT ManCo ApS?
Jakob Juul Rasmussen, Søren Winkel, Peter-Emil Iversen are the CEOs of Pharma IT ManCo ApS.
Who is the auditor of Pharma IT ManCo ApS?
Pharma IT ManCo ApS most recently used REDMARK, GODKENDT REVISIONSPARTNERSELSKAB.
When was Pharma IT ManCo ApS founded?
Pharma IT ManCo ApS was founded on 15 June 2022.
What is the equity of Pharma IT ManCo ApS?
Equity was DKK 27.7m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.